This is of course why in countries with controlled economies they never
have to worry about "risking unintended bad consequences".
Because they don't have the substance either.
Harry
________________________________-
Brad wrote (see below):
>>From today's (Sun, 26 Apr 98) New York Times:
>
>There is a serious shortage
>(in the United States) of a vital drug made from blood
>plasma, which certain persons with compromised
>immune systems need to live. With the drug, many of
>them live normal lives; without it, they get all
>sorts of infections (and, presumably, die, or at
>least, as one patient says, it: "tak[es] my life
>away as I know it" (p. 1). The
>source of the problem is complicated (article
>begins on Page 1), but it is all tied up with
>issues of the "business case" for (i.e., against!)
>pharmaceutical companies producing the drug. Here's
>the reason I'm calling attention to this story:
>
> "With lives in the balance, this should be
> fixed," said Dr. Arthut Caplan, Chairman of the
> blood advisory committee of Health and Human Services.
> "But when you leave the supply of a vital substance
> simply in the hands of the free market, and you don't
> keep an eye on what is going on, you will wind up
*****************************
Harry Pollard (818) 352-4141
Henry George School of Los Angeles
Box 655
Tujunga CA 91042
*****************************
